Impact of Chemotherapy on Prognosis of Resectable Pathological T3N0M0 Esophageal Cancer Patients: A Population-Based Study

References

• Hsu P-K , HuangC-S, WangB-Y, WuY-C, HsuW-H. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma. Ann. Thorac. Surg.97(5), 1734–1741 (2014).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Gupta B , KumarN. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur. J. Cancer Prev.26(2), 107–118 (2017).
   PubMed Web of Science ®Google Scholar
• Feng RM , ZongYN, CaoSM, XuRH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. (Lond.)39(1), 22 (2019).
   PubMed Web of Science ®Google Scholar
• Chitti B , PhamA, MarcottSet al. Temporal changes in esophageal cancer mortality by geographic region: a population-based analysis. Cureus10(11), e3596 (2018).
   PubMedGoogle Scholar
• Liu T , LiuW, ZhangH, RenC, ChenJ, DangJ. The role of postoperative radiotherapy for radically resected esophageal squamous cell carcinoma: a systemic review and meta-analysis. J. Thorac. Dis.10(7), 4403–4412 (2018).
   PubMed Web of Science ®Google Scholar
• William HA . Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J. Clin. Oncol.27(30), 5062–5067 (2009).
   PubMed Web of Science ®Google Scholar
• Oppedijk V , GaastA, LanschotJet al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS Trials. J. Clin. Oncol.32(5), 385–391 (2014).
   PubMed Web of Science ®Google Scholar
• Kang J , ChangJ, SunX, MenY, ZengH, HuiZ. Role of postoperative concurrent chemoradiotherapy for esophageal carcinoma: a meta-analysis of 2165 patients. J. Cancer9(3), 584–593 (2018).
   PubMed Web of Science ®Google Scholar
• NationalComprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology.Esophageal and Esophagogastric Junction Cancers (2019). https://www.nccn.org/professionals/physician_gls/f_guidelines.asp
   Google Scholar
• Ando N , IizukaT, IdeHet al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study – JCOG9204. J. Clin. Oncol.21(24), 4592–4596 (2003).
   PubMed Web of Science ®Google Scholar
• Forner A , ReigM, BruixJ. Hepatocellular carcinoma. Lancet391(10127), 1301–1314 (2018).
   PubMed Web of Science ®Google Scholar
• Han L , DaiW, MoSet al. Nomogram to predict the risk and survival of synchronous bonemetastasis in colorectal cancer: a population-based real-worldanalysis. Int J Colorectal Dis.35(8), 1575–1585 (2020).
   PubMed Web of Science ®Google Scholar
• Ge Y , YinL, TanMet al. Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: a population-based study. Clin. Transl. Med.10(3), e143 (2020).
   PubMed Web of Science ®Google Scholar
• Mantziari S , GronnierC, RenaudFet al. Survival benefit of neoadjuvant treatment in clinical T3N0M0 esophageal cancer: results from a retrospective multicenter European study. Ann. Surg.266(5), 805–813 (2017).
   PubMed Web of Science ®Google Scholar
• Kim J , BowlbyR, MungallAet al. Integrated genomic characterization of oesophageal carcinoma. Nature541(7636), 169–175 (2017).
   PubMed Web of Science ®Google Scholar
• Kleinberg L , ForastiereAA. Chemoradiation in the management of esophageal cancer. J. Clin. Oncol.25(26), 4110–4117 (2007).
   PubMed Web of Science ®Google Scholar
• Medical Research Council Oesophageal Cancer Working Group . Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet359(9319), 1727–1733 (2002).
   PubMed Web of Science ®Google Scholar
• Cunningham D , AllumWH, StenningSPet al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355(1), 11–20 (2006).
   PubMed Web of Science ®Google Scholar
• Sjoquist KM , BurmeisterBH, SmithersBMet al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol.12(7), 681–692 (2011).
   PubMed Web of Science ®Google Scholar
• Lv J , CaoXF, ZhuB, JiL, TaoL, WangDD. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J. Gastroenterol.16(13), 1649–1654 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang X , YangY, SunYet al. Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma. J. Thorac. Dis.11(6), 2512–2522 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Q , PengL, LiTet al. Postoperative chemotherapy for thoracic pathological T3N0M0 esophageal squamous cell carcinoma. Ann. Surg. Oncol.27(5), 1488–1495 (2020).
   PubMedGoogle Scholar
• Shapiro J , van LanschotJJB, HulshofMet al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol.16(9), 1090–1098 (2015).
   PubMed Web of Science ®Google Scholar
• Van Hagen P , HulshofMC, Van LanschotJJet al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med.366(22), 2074–2084 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang SS , YangH, XieXet al. Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Dis. Esophagus27(6), 574–584 (2014).
   PubMed Web of Science ®Google Scholar
• Lau B , ColeSR, GangeSJ. Competing risk regression models for epidemiologic data. Am. J. Epidemiol.170(2), 244–256 (2009).
   PubMed Web of Science ®Google Scholar
• Hankins JR , ColeFN, AttarS, McLaughlinJS. Carcinoma of the esophagus: twelve years' experience with a philosophy for palliation. Ann. Thorac. Surg.33(5), 464–472 (1982).
   PubMed Web of Science ®Google Scholar
• Schreiber D , RineerJ, VongtamaDet al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J. Thorac. Oncol.5(2), 244–250 (2010).
   PubMed Web of Science ®Google Scholar
• Zieren H , MüllerJM, JacobiC, PichlmaierH, MüllerR, StaarS. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J. Surg.19(3), 444–449 (1995).
   PubMed Web of Science ®Google Scholar
• Ténière P , HayJ, FingerhutA, FagniezP. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg. Gynecol. Obstet.173(2), 123–130 (1991).
   PubMedGoogle Scholar
• Fok M , ShamJ, ChoyD, ChengS, WongJ. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery113(2), 138–147 (1993).
   PubMed Web of Science ®Google Scholar
• Yang J , ZhangW, XiaoZet al. The impact of postoperative conformal radiotherapy after radical surgery on survival and recurrence in pathologic T3N0M0 esophageal carcinoma: a propensity score-matched analysis. J. Thorac. Oncol.12(7), 1143–1151 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang W , LiuX, XiaoZet al. Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma. Oncol. Res. Treat.38(3), 97–102 (2015).
   PubMed Web of Science ®Google Scholar
• Zou B , PangJ, LiuYet al. Postoperative chemoradiotherapy improves survival in patients with stage II–III esophageal squamous cell carcinoma: an analysis of clinical outcomes. Thorac. Cancer7(5), 515–521 (2016).
   PubMed Web of Science ®Google Scholar
• Luo H-S , HuangH-C, LinL-X. Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis. Radiat. Oncol.14(1), 178 (2019).
   PubMed Web of Science ®Google Scholar